Brief: Gain Presents Data On Gaucher Disease Program
29/03/2022 13:10
March 29 (Reuters) - Gain Therapeutics Inc GANX.O :
* GAIN THERAPEUTICS PRESENTS ADDITIONAL CONFIRMATORY DATA ON
ITS
GAUCHER DISEASE PROGRAM AT THE 2022 GLYCOLIPID AND SPHINGOLIPID
BIOLOGY GORDON RESEARCH CONFERENCE
Source text for Eikon: ID:nGNX1PKZXl
Further company coverage: GANX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Gain Therapeutics
See all newsU.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil,
Gain Therapeutics climbs on narrower-than-expected quarterly loss
Gain Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Gain Therapeutics Q2 net loss per share narrows as R&D expenses fall